MX384485B - Deteccion temprana de preeclampsia. - Google Patents

Deteccion temprana de preeclampsia.

Info

Publication number
MX384485B
MX384485B MX2016012278A MX2016012278A MX384485B MX 384485 B MX384485 B MX 384485B MX 2016012278 A MX2016012278 A MX 2016012278A MX 2016012278 A MX2016012278 A MX 2016012278A MX 384485 B MX384485 B MX 384485B
Authority
MX
Mexico
Prior art keywords
preeclampsia
subject
early detection
anxa2
level
Prior art date
Application number
MX2016012278A
Other languages
English (en)
Spanish (es)
Other versions
MX2016012278A (es
Inventor
Antonio Pellicer
Carlos Simon
Tamara Garrido
Original Assignee
Igenomix S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igenomix S L filed Critical Igenomix S L
Publication of MX2016012278A publication Critical patent/MX2016012278A/es
Publication of MX384485B publication Critical patent/MX384485B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2016012278A 2014-03-21 2015-03-19 Deteccion temprana de preeclampsia. MX384485B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461968728P 2014-03-21 2014-03-21
US201461969520P 2014-03-24 2014-03-24
PCT/IB2015/001404 WO2015166353A2 (en) 2014-03-21 2015-03-19 Early detection of preeclampsia

Publications (2)

Publication Number Publication Date
MX2016012278A MX2016012278A (es) 2017-04-27
MX384485B true MX384485B (es) 2025-03-14

Family

ID=54147245

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012278A MX384485B (es) 2014-03-21 2015-03-19 Deteccion temprana de preeclampsia.

Country Status (8)

Country Link
US (1) US20170097358A1 (https=)
EP (1) EP3120152A2 (https=)
JP (1) JP6684263B2 (https=)
CN (2) CN110927385A (https=)
BR (1) BR112016021630A2 (https=)
CA (1) CA2943284A1 (https=)
MX (1) MX384485B (https=)
WO (1) WO2015166353A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US11129851B2 (en) 2014-06-17 2021-09-28 Igenomix S.L. Stem cell therapy in endometrial pathologies
CA3074808A1 (en) * 2017-09-05 2019-03-14 Igenomix S.L. Methods and devices for detecting biomarkers associated with preeclampsia
CA3093206A1 (en) * 2018-03-06 2019-09-12 Christine Metz Methods for detecting and treating endometriosis
CN114990038B (zh) * 2022-05-24 2023-06-27 郑州大学 一种细菌外膜囊泡及其在制备先兆子痫治疗药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712103A (en) * 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
CN101616927A (zh) * 2005-09-15 2009-12-30 迪爱麦有限公司 诊断先兆子痫的方法
CN101680884A (zh) * 2007-05-05 2010-03-24 西安大略大学 检测先兆子痫的方法
EP2019318A1 (en) * 2007-07-27 2009-01-28 Erasmus University Medical Center Rotterdam Protein markers for cardiovascular events
CN105403701B (zh) * 2008-04-11 2017-04-12 中国医学科学院肿瘤医院 膜联蛋白a2的血清检测方法、检测试剂盒及其应用
WO2009143633A1 (en) 2008-05-30 2009-12-03 Institut De Recherches Cliniques De Montreal Pcsk9 inhibitors and methods of use thereof
CN107677828A (zh) * 2008-10-31 2018-02-09 耶鲁大学 子痫前期检测和治疗的方法和组合物
US20120107825A1 (en) * 2010-11-01 2012-05-03 Winger Edward E Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna
EP2678448A4 (en) * 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
US9423402B2 (en) * 2011-11-30 2016-08-23 Singapore Health Services Pte. Ltd. GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
MX356775B (es) * 2012-06-27 2018-06-13 Hoffmann La Roche Medios y metodos que aplican sflt-1/plgf o relacion de endoglina/plgf para descartar el inicio de preeclampsia en un determinado periodo de tiempo.
CN103436552A (zh) * 2013-09-10 2013-12-11 浙江大学 一种人源annexin A2的生产方法及其应用

Also Published As

Publication number Publication date
CN110927385A (zh) 2020-03-27
JP6684263B2 (ja) 2020-04-22
BR112016021630A2 (pt) 2020-02-27
JP2017513021A (ja) 2017-05-25
EP3120152A2 (en) 2017-01-25
US20170097358A1 (en) 2017-04-06
CA2943284A1 (en) 2015-11-05
MX2016012278A (es) 2017-04-27
CN106662589B (zh) 2019-07-30
WO2015166353A3 (en) 2016-01-21
WO2015166353A2 (en) 2015-11-05
CN106662589A (zh) 2017-05-10

Similar Documents

Publication Publication Date Title
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
MX2016013261A (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
BR112016029634A2 (pt) kit, dispositivo e método para a detecção de câncer de fígado
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
BR112016029583A2 (pt) ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção?
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
BR112016002668A2 (pt) métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
WO2015131151A3 (en) Method and apparatus for determining markers of health by analysis of blood
EP3415912A4 (en) ANALYT DETECTION PROCEDURE AND REAGENT SET TO DETECT ANALYTES
MX384485B (es) Deteccion temprana de preeclampsia.
MX2016009450A (es) Ensayo novedoso para detectar periostina humana.
EA201700208A1 (ru) Способ и устройство для обнаружения малярии
BR112016013976A2 (pt) método para determinar se um indivíduo é afetado por um câncer, método para discriminar entre câncer colorretal e pancreático dentre indivíduos que resultam ser positivos para o método, método para determinar o estágio de um câncer colorretal em um indivíduo afetado e uso de um kit de rt-pcr quantitativo para performar o método
MX377026B (es) Biomarcadores para la progresión de enfermedades en melanoma.
MA40636A (fr) Procédés pour détecter le cancer de la prostate
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
MX2015013993A (es) Procedimientos y series para su uso en los mismos.
MX2016007148A (es) Metodos de ensayo de beta-glucano.
GB201206323D0 (en) Methods and arrays for use in the same
PL406989A1 (pl) Profil mikro RNA we krwi jako test wykrywania raka płuca